SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency

Schlotawa L, Ennemann E, Radhakrishnan K, Schmidt B, Chakrapani A, Christen H-J, Moser H, Steinmann B, Dierks T, Gaertner J (2011)
European Journal of Human Genetics 19(3): 253-261.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ;
Abstract / Bemerkung
Multiple Sulfatase Deficiency (MSD) is caused by mutations in the sulfatase-modifying factor 1 gene encoding the formylglycine-generating enzyme (FGE). FGE post translationally activates all newly synthesized sulfatases by generating the catalytic residue formylglycine. Impaired FGE function leads to reduced sulfatase activities. Patients display combined clinical symptoms of single sulfatase deficiencies. For ten MSD patients, we determined the clinical phenotype, FGE expression, localization and stability, as well as residual FGE and sulfatase activities. A neonatal, very severe clinical phenotype resulted from a combination of two nonsense mutations leading to almost fully abrogated FGE activity, highly unstable FGE protein and nearly undetectable sulfatase activities. A late infantile mild phenotype resulted from FGE G263V leading to unstable protein but high residual FGE activity. Other missense mutations resulted in a late infantile severe phenotype because of unstable protein with low residual FGE activity. Patients with identical mutations displayed comparable clinical phenotypes. These data confirm the hypothesis that the phenotypic outcome in MSD depends on both residual FGE activity as well as protein stability. Predicting the clinical course in case of molecularly characterized mutations seems feasible, which will be helpful for genetic counseling and developing therapeutic strategies aiming at enhancement of FGE. European Journal of Human Genetics (2011) 19, 253-261; doi:10.1038/ejhg.2010.219; published online 12 January 2011
Erscheinungsjahr
Zeitschriftentitel
European Journal of Human Genetics
Band
19
Zeitschriftennummer
3
Seite
253-261
ISSN
eISSN
PUB-ID

Zitieren

Schlotawa L, Ennemann E, Radhakrishnan K, et al. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics. 2011;19(3):253-261.
Schlotawa, L., Ennemann, E., Radhakrishnan, K., Schmidt, B., Chakrapani, A., Christen, H. - J., Moser, H., et al. (2011). SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics, 19(3), 253-261. doi:10.1038/ejhg.2010.219
Schlotawa, L., Ennemann, E., Radhakrishnan, K., Schmidt, B., Chakrapani, A., Christen, H. - J., Moser, H., Steinmann, B., Dierks, T., and Gaertner, J. (2011). SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics 19, 253-261.
Schlotawa, L., et al., 2011. SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics, 19(3), p 253-261.
L. Schlotawa, et al., “SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency”, European Journal of Human Genetics, vol. 19, 2011, pp. 253-261.
Schlotawa, L., Ennemann, E., Radhakrishnan, K., Schmidt, B., Chakrapani, A., Christen, H.-J., Moser, H., Steinmann, B., Dierks, T., Gaertner, J.: SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency. European Journal of Human Genetics. 19, 253-261 (2011).
Schlotawa, Lars, Ennemann, Eva, Radhakrishnan, Karthikeyan, Schmidt, Bernhard, Chakrapani, Anupam, Christen, Hans-Juergen, Moser, Hugo, Steinmann, Beat, Dierks, Thomas, and Gaertner, Jutta. “SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency”. European Journal of Human Genetics 19.3 (2011): 253-261.

14 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The report of two cases with multiple sulfatase deficiency resulting from a rare similar gene mutation.
Ashrafzadeh F, Zabolinejad N, Ghayoor Karimiani E, Beiraghi Toosi M, Doniadideh N, Torabi S, Razmyar M, Sheikh Andalibi MS., Int J Dermatol (), 2018
PMID: 29479672
Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.
Weidner J, Jarenbäck L, de Jong K, Vonk JM, van den Berge M, Brandsma CA, Boezen HM, Sin D, Bossé Y, Nickle D, Ankerst J, Bjermer L, Postma DS, Faiz A, Tufvesson E., Respir Res 18(1), 2017
PMID: 28464818
Clinical and molecular cytogenetic analyses of four patients with imbalanced translocations.
Liu HY, Huang J, Li T, Wu D, Wang HD, Wang Y, Wang T, Guo LJ, Guo QN, Huang FF, Wang RL, Wang YT., Mol Cytogenet 9(), 2016
PMID: 27099631
Protecting the mitochondrial powerhouse.
Scheibye-Knudsen M, Fang EF, Croteau DL, Wilson DM, Bohr VA., Trends Cell Biol 25(3), 2015
PMID: 25499735
Natural disease history and characterisation of SUMF1 molecular defects in ten unrelated patients with multiple sulfatase deficiency.
Sabourdy F, Mourey L, Le Trionnaire E, Bednarek N, Caillaud C, Chaix Y, Delrue MA, Dusser A, Froissart R, Garnotel R, Guffon N, Megarbane A, Ogier de Baulny H, Pédespan JM, Pichard S, Valayannopoulos V, Verloes A, Levade T., Orphanet J Rare Dis 10(), 2015
PMID: 25885655
Microduplications of 3p26.3p26.2 containing CRBN gene in patients with intellectual disability and behavior abnormalities.
Papuc SM, Hackmann K, Andrieux J, Vincent-Delorme C, Budişteanu M, Arghir A, Schrock E, Ţuţulan-Cuniţă AC, Di Donato N., Eur J Med Genet 58(5), 2015
PMID: 25858704
The Regulation of Steroid Action by Sulfation and Desulfation.
Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA., Endocr Rev 36(5), 2015
PMID: 26213785
A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome.
Chung YK, Sohn YB, Sohn JM, Lee J, Chang MS, Kwun Y, Kim CH, Lee JY, Yook YJ, Ko AR, Jin DK., Glycoconj J 31(4), 2014
PMID: 24781369
Molecular evaluation of a novel missense mutation & an insertional truncating mutation in SUMF1 gene.
Kotecha UH, Movva S, Sharma D, Verma J, Puri RD, Verma IC., Indian J Med Res 140(1), 2014
PMID: 25222778
Case of multiple sulfatase deficiency and ocular albinism: a diagnostic odyssey.
Prasad C, Rupar CA, Campbell C, Napier M, Ramsay D, Tay KY, Sharan S, Prasad AN., Can J Neurol Sci 41(5), 2014
PMID: 25373814
Multiple sulfatase deficiency with neonatal manifestation.
Garavelli L, Santoro L, Iori A, Gargano G, Braibanti S, Pedori S, Melli N, Frattini D, Zampini L, Galeazzi T, Padella L, Pepe S, Wischmeijer A, Rosato S, Ivanovski I, Iughetti L, Gelmini C, Bernasconi S, Superti-Furga A, Ballabio A, Gabrielli O., Ital J Pediatr 40(), 2014
PMID: 25516103
Rapid degradation of an active formylglycine generating enzyme variant leads to a late infantile severe form of multiple sulfatase deficiency.
Schlotawa L, Radhakrishnan K, Baumgartner M, Schmid R, Schmidt B, Dierks T, Gärtner J., Eur J Hum Genet 21(9), 2013
PMID: 23321616

45 References

Daten bereitgestellt von Europe PubMed Central.

Molecular and functional analysis of SUMF1 mutations in multiple sulfatase deficiency.
Cosma MP, Pepe S, Parenti G, Settembre C, Annunziata I, Wade-Martins R, Di Domenico C, Di Natale P, Mankad A, Cox B, Uziel G, Mancini GM, Zammarchi E, Donati MA, Kleijer WJ, Filocamo M, Carrozzo R, Carella M, Ballabio A., Hum. Mutat. 23(6), 2004
PMID: 15146462
Multiple sulfatase deficiency: clinical report and description of two novel mutations in a Brazilian patient.
Artigalas OA, da Silva LR, Burin M, Pastores GM, Zeng B, Macedo N, Schwartz IV., Metab Brain Dis 24(3), 2009
PMID: 19697114
A newly recognized cause of low urinary estriol in pregnancy: multiple sulfatase deficiency of the fetus.
Steinmann B, Mieth D, Gitzelmann R., Gynecol. Obstet. Invest. 12(2), 1981
PMID: 7262633
Molecular characterization of the human Calpha-formylglycine-generating enzyme.
Preusser-Kunze A, Mariappan M, Schmidt B, Gande SL, Mutenda K, Wenzel D, von Figura K, Dierks T., J. Biol. Chem. 280(15), 2005
PMID: 15657036
Multiple sulfatase deficiency: catalytically inactive sulfatases are expressed from retrovirally introduced sulfatase cDNAs
Rommerskirch W, von K., 1992
A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease).
Voznyi YV, Keulemans JL, van Diggelen OP., J. Inherit. Metab. Dis. 24(6), 2001
PMID: 11768586
The non-catalytic N-terminal extension of formylglycine-generating enzyme is required for its biological activity and retention in the endoplasmic reticulum.
Mariappan M, Gande SL, Radhakrishnan K, Schmidt B, Dierks T, von Figura K., J. Biol. Chem. 283(17), 2008
PMID: 18305113
A general binding mechanism for all human sulfatases by the formylglycine-generating enzyme
Roeser D, Preusser-Kunze A, Schmidt B., 2006
Characterization of posttranslational formylglycine formation by luminal components of the endoplasmic reticulum.
Fey J, Balleininger M, Borissenko LV, Schmidt B, von Figura K, Dierks T., J. Biol. Chem. 276(50), 2001
PMID: 11600503
One step at a time: endoplasmic reticulum-associated degradation.
Vembar SS, Brodsky JL., Nat. Rev. Mol. Cell Biol. 9(12), 2008
PMID: 19002207
Multistep, sequential control of the trafficking and function of the multiple sulfatase deficiency gene product, SUMF1 by PDI, ERGIC-53 and ERp44.
Fraldi A, Zito E, Annunziata F, Lombardi A, Cozzolino M, Monti M, Spampanato C, Ballabio A, Pucci P, Sitia R, Cosma MP., Hum. Mol. Genet. 17(17), 2008
PMID: 18508857
Sulfatase modifying factor 1 trafficking through the cells: from endoplasmic reticulum to the endoplasmic reticulum.
Zito E, Buono M, Pepe S, Settembre C, Annunziata I, Surace EM, Dierks T, Monti M, Cozzolino M, Pucci P, Ballabio A, Cosma MP., EMBO J. 26(10), 2007
PMID: 17446859
Synthesis and stability of steroid sulfatase in fibroblasts from multiple sulfatase deficiency.
Conary JT, Hasilik A, von Figura K., Biol. Chem. Hoppe-Seyler 369(4), 1988
PMID: 3165268
Multiple sulfatase deficiency: degradation of arylsulfatase A and B after endocytosis in fibroblasts.
Steckel F, Hasilik A, von Figura K., Eur. J. Biochem. 151(1), 1985
PMID: 2863139
Synthesis and stability of arylsulfatase A and B in fibroblasts from multiple sulfatase deficiency.
Steckel F, Hasilik A, von Figura K., Eur. J. Biochem. 151(1), 1985
PMID: 2863138
Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
Sawkar AR, Adamski-Werner SL, Cheng WC, Wong CH, Beutler E, Zimmer KP, Kelly JW., Chem. Biol. 12(11), 2005
PMID: 16298303
Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
Ulloa-Aguirre A, Janovick JA, Brothers SP, Conn PM., Traffic 5(11), 2004
PMID: 15479448

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 21224894
PubMed | Europe PMC

Suchen in

Google Scholar